2022
DOI: 10.1177/19418744221097350
|View full text |Cite
|
Sign up to set email alerts
|

Facial Diplegia as the Sole Manifestation of Post-Vaccination Guillain-Barre Syndrome: A Case Report and Literature Review

Abstract: Introduction: Recently, a large study concluded that certain brands of vaccines may increase the risk of Bell’s palsy and Guillain Barre Syndrome (GBS). As to whether vaccination after COVID-19 modify the risk of Bell’s palsy or GBS has not yet been studied. Case: Here we report a 35 years old COVID-19 survivor whom in less than 2 weeks after his second dose of inactivated SARS-CoV2 vaccine, developed bilateral facial nerve paralysis. In addition, he had hyperacusis, dysgeusia and decreased lacrimation without… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 14 publications
0
8
1
1
Order By: Relevance
“…We also disagree with the statement that a brainstem lesion was ruled out because it would lead to multiple cranial nerve lesions and limb weakness in addition to abnormal cranial imaging 1 . First, a cerebral CT-scan is not sufficient to rule out brainstem encephalitis.…”
Section: Letter To the Editormentioning
confidence: 67%
See 4 more Smart Citations
“…We also disagree with the statement that a brainstem lesion was ruled out because it would lead to multiple cranial nerve lesions and limb weakness in addition to abnormal cranial imaging 1 . First, a cerebral CT-scan is not sufficient to rule out brainstem encephalitis.…”
Section: Letter To the Editormentioning
confidence: 67%
“…With interest we read the article by Prado et al about a 35 years-old male who developed facial diplegia 10 days after the second dose of an anti-SARS-CoV-2 vaccination with an inactivated strain. 1 The patient was diagnosed with Guillain-Barre syndrome (GBS), subtype cranial nerve affection, and profited from steroids. 1 The study is promising but raises concerns that should be discussed.…”
Section: Letter To the Editormentioning
confidence: 99%
See 3 more Smart Citations